Plain-English translation of NCT04432025 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Obesity research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
After weight loss surgery, people with type 2 diabetes often see their blood sugar improve dramatically — sometimes so much that they can stop taking diabetes medications. However, most people's diabetes comes back within five years. This study is testing whether continuing diabetes medications after surgery might help keep blood sugar controlled for longer.
Currently, doctors stop all diabetes medications right after weight loss surgery and only restart them if symptoms return. But since 80% of patients experience diabetes relapse within five years, researchers want to find out if keeping patients on the medication — carefully adjusted to their needs — could prevent that relapse and help them stay healthier long-term.
You likely qualify if…
You likely don't qualify if…
You will have weight loss surgery (either a gastric bypass or sleeve gastrectomy). After surgery, you'll be randomly assigned to one of two groups: one group will have their diabetes care managed by their regular doctor, while the other group will receive ongoing, carefully adjusted diabetes medications with regular check-ups to monitor blood sugar, blood pressure, and cholesterol. The study will follow you long-term to see which approach helps prevent diabetes from coming back.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
Ireland